Beta-blockers in psychiatry.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D001008:Anxiety Disorders / Q000188:drug therapy; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D013001:Somatoform Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D011433:Propranolol